Export

ATC codes: R03BA02
EMLc
Indication
Asthma ICD11 code: CA23
INN
Budesonide
Medicine type
Chemical agent
List type
Core
Formulations
Respiratory > Inhalation > aerosol: 100 µg per dose (EMLc) ; 200 µg per dose (EMLc)
EML status history
First added in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Sex
All
Age
Children (1 month - 12 years)
Therapeutic equivalence
Medicines within the same pharmacological class can be used
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Comments on budesonide as listed in the 2nd edition of the EMLc were received from Cécile Mace, Asthma Drug Facility Coordinator, Quality Assurance Pharmacist, International Union Against Tuberculosis and Lung Disease. The Committee noted that Miss Mace had correctly pointed out the errors in the description of budesonide metered dose inhlaers with reference to strengths and the salt “dipropionate”. The Committee approved the corrected version as: budesonide Inhalation (aerosol): 100 micrograms per dose and 200 micrograms per dose. The Committee noted the confusion arising from this error as to whether budesonide or beclometasone is the corticosteroid included in the EMLc, and confirmed that budesonide was chosen as it is more widely available.